ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Tin Fluorides

Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.

Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.

Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Feb 6, 201547 company-led studies, 4 open or runningNext primary completion: Sep 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmoliveits history only182 open or runningphase 4since Feb 6, 2015Sep 26, 2008Sep 2027phase 4 · NCT07807397
Procter and Gambleits history only142 open or runningphase 4since Aug 28, 2025Feb 28, 2012none ahead
GlaxoSmithKline80 open or runningphase 3since May 3, 2012May 3, 2012none ahead
HALEONits history only40 open or runningno phasesince Nov 16, 2023Nov 16, 2023none ahead
Church & Dwightits history only30 open or runningno phasesince Feb 12, 2026Feb 12, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 3, 2012First studies: 2 phase 3 studies in Dentin SensitivityFirst studyNCT01592864, NCT01592851
  2. Apr 5, 2013Phase 3 study in Dentin SensitivityNCT01827670 · 119 enrolled · United States
  3. Nov 2, 2015No phase study in GingivitisNCT02750943 · 253 enrolled · United States
  4. Mar 28, 2016Phase 3 study in Dentin SensitivityNCT02832375 · 242 enrolled · United States
  5. Apr 25, 2016No phase study in Dentin SensitivityNCT02752958 · 75 enrolled · United Kingdom
  6. Mar 2, 2017Phase 3 study in Dentin SensitivityNCT03072719 · 120 enrolled · Ireland
  7. Oct 10, 2019Phase 3 study in GingivitisNCT04123665 · 98 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 8 GlaxoSmithKline leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT04123665Gingivitis · United States3CompletedDec 11, 201398
NCT03072719Dentin Sensitivity · Ireland3CompletedJun 1, 2012120
NCT02752958Dentin Sensitivity · United Kingdom–CompletedFeb 1, 201775
NCT02832375Dentin Sensitivity · United States3CompletedMay 1, 2016242
NCT02750943Gingivitis · United States–CompletedMar 1, 2016253
NCT01827670Dentin Sensitivity · United States3CompletedMay 2013119
NCT01592864Dentin Sensitivity · United States3CompletedMay 2012120
NCT01592851Dentin Sensitivity · United States3CompletedMay 2012113

How it is read

Names in the registry

  • “0.454% Stannous Fluoride Dentifrice”, 8 entries
  • “Stannous fluoride toothpaste”, 7 entries
  • “Stannous Fluoride”, 6 entries
  • “stannous fluoride toothpaste”, 5 entries
  • “Stannous Fluoride Toothpaste (SnF)”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.